New generation of blood-thinning drugs found safe for older adults
New generation of blood-thinning drugs found safe for older adults
Older people are not at higher risk of harmful complications from taking the newest generation of blood-thinning drugs (anticoagulants), says a study in the Journal of the American Geriatrics Society.
The new anticoagulants are apixaban (Eliquis), dabigatran (Pradaxa), and rivaroxaban (Xarelto). They are alternatives to warfarin (Coumadin), still the leading medication for preventing blood clots that can cause strokes.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.